171 related articles for article (PubMed ID: 20849606)
1. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.
Stein A; Knödler M; Makowski M; Kühnel S; Nekolla S; Keithahn A; Weidl E; Groha P; Schürmann M; Saraste A; Botnar R; Oostendorp RA; Ott I
BMC Cardiovasc Disord; 2010 Sep; 10():43. PubMed ID: 20849606
[TBL] [Abstract][Full Text] [Related]
2. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
Cheng Y; Hu R; Lv L; Ling L; Jiang S
J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Insulin-Like Growth Factor-2 in Expanded Endothelial Progenitor Cells Improves Left Ventricular Function in Experimental Myocardial Infarction.
Demetz G; Oostendorp RAJ; Boxberg AM; Sitz W; Farrell E; Steppich B; Steinsiek AL; Rudelius M; Ott I
J Vasc Res; 2017; 54(6):321-328. PubMed ID: 28950284
[TBL] [Abstract][Full Text] [Related]
7. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
Klopsch C; Furlani D; Gäbel R; Li W; Pittermann E; Ugurlucan M; Kundt G; Zingler C; Titze U; Wang W; Ong LL; Wagner K; Li RK; Ma N; Steinhoff G
J Cell Mol Med; 2009 Apr; 13(4):664-79. PubMed ID: 19449462
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
9. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia.
Kupatt C; Horstkotte J; Vlastos GA; Pfosser A; Lebherz C; Semisch M; Thalgott M; Büttner K; Browarzyk C; Mages J; Hoffmann R; Deten A; Lamparter M; Müller F; Beck H; Büning H; Boekstegers P; Hatzopoulos AK
FASEB J; 2005 Sep; 19(11):1576-8. PubMed ID: 16009705
[TBL] [Abstract][Full Text] [Related]
10. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor.
Tavakoli F; Ostad SN; Khori V; Alizadeh AM; Sadeghpour A; Darbandi Azar A; Haghjoo M; Zare A; Nayebpour M
Eur J Pharmacol; 2013 Aug; 714(1-3):456-63. PubMed ID: 23850947
[TBL] [Abstract][Full Text] [Related]
11. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.
Prunier F; Pfister O; Hadri L; Liang L; Del Monte F; Liao R; Hajjar RJ
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H522-9. PubMed ID: 16997893
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
[TBL] [Abstract][Full Text] [Related]
14. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
[TBL] [Abstract][Full Text] [Related]
15. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.
Klopsch C; Skorska A; Ludwig M; Lemcke H; Maass G; Gaebel R; Beyer M; Lux C; Toelk A; Müller K; Maschmeier C; Rohde S; Mela P; Müller-Hilke B; Jockenhoevel S; Vollmar B; Jaster R; David R; Steinhoff G
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752300
[TBL] [Abstract][Full Text] [Related]
16. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.
Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K
Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026
[TBL] [Abstract][Full Text] [Related]
17. Effects of erythropoietin on angiogenesis after myocardial infarction in porcine.
Kawachi K; Iso Y; Sato T; Wakabayashi K; Kobayashi Y; Takeyama Y; Suzuki H
Heart Vessels; 2012 Jan; 27(1):79-88. PubMed ID: 22038108
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
Hirata A; Minamino T; Asanuma H; Fujita M; Wakeno M; Myoishi M; Tsukamoto O; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Shiraga M; Kitakaze M; Hori M
J Am Coll Cardiol; 2006 Jul; 48(1):176-84. PubMed ID: 16814664
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction.
Xue J; Du G; Shi J; Li Y; Yasutake M; Liu L; Li J; Kong Y; Wang S; Yun F; Li W
Chin Med J (Engl); 2014; 127(9):1677-83. PubMed ID: 24791874
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
